Cargando…
Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients’
BACKGROUND: Elevated Interleukin-6 (IL-6) may play an important role in the pathophysiology of COVID-19 yet attenuated response is not seen across all severe patients. We aimed to determine the effect of IL-6 baseline levels and other clinical variables on mortality and outcomes in hospitalized COVI...
Autores principales: | Smieszek, Sandra P., Przychodzen, Bartlomiej P., Polymeropoulos, Vasilios M., Polymeropoulos, Christos M., Polymeropoulos, Mihael H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318728/ https://www.ncbi.nlm.nih.gov/pubmed/34353696 http://dx.doi.org/10.1016/j.cyto.2021.155662 |
Ejemplares similares
-
Corrigendum to “Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients” [Cytokine 148 (2021) 155662]
por: Smieszek, Sandra P., et al.
Publicado: (2022) -
Elevated plasma levels of CXCL16 in severe COVID-19 patients
por: Smieszek, Sandra P., et al.
Publicado: (2022) -
Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibility
por: Smieszek, Sandra P., et al.
Publicado: (2021) -
Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment
por: Smieszek, Sandra P., et al.
Publicado: (2020) -
Case report: A novel missense variant in melanopsin associates with delayed sleep phenotype: Whole genome sequencing study
por: Smieszek, Sandra P., et al.
Publicado: (2022)